Open Stage Seminar Oct. 11 (Thu.) 13:00 ~ 13:50

Hitachi Chemical

Robert A Preti

General Manager, Regenerative Medicine Business Sector

Addressing the Global Delivery Challenge for Regenerative Medicine

Led by the transformative success of the cellular immunotherapy market, companies are searching for what we call “deliverability” - higher quality, lower COGs, scalability and sustainability of their future and supply chains. Barriers to this expansion include manual labor-based manufacturing platforms, a fragmented global market, a complex supply chain requiring multiple reagents in development and cultural barriers. The Hitachi Chemical Regenerative Medicine Business Sector is addressing challenges through development of existing capabilities and new commercial capabilities, the establishment of a global footprint and the development of a future-state technology-driven superior delivery platform.

Window Close